F019-6063 Screening compound: N1-(2-FURYLMETHYL)-2-[1-(1-METHYL-1H-INDOL-3-YL)-3-OXO-1

F019-6063 Screening compound: N1-(2-FURYLMETHYL)-2-[1-(1-METHYL-1H-INDOL-3-YL)-3-OXO-1
F019-6063 Screening compound: N1-(2-FURYLMETHYL)-2-[1-(1-METHYL-1H-INDOL-3-YL)-3-OXO-1 alternative view

Chemical Structure Depiction of ChemDiv screening compound F019-6063
N1-(2-FURYLMETHYL)-2-[1-(1-METHYL-1H-INDOL-3-YL)-3-OXO-1

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F019-6063

Molecular Formula

C24H21N3O3 (C24 H21 N3 O3)

Compound Name

N1-(2-FURYLMETHYL)-2-[1-(1-METHYL-1H-INDOL-3-YL)-3-OXO-1

IUPAC name

n/a

SMILES

Cn1c(cccc2)c2c(C(c2c3cccc2)N(CC(NCc2ccco2)=O)C3=O)c1

InChI

InChI=1S/C24H21N3O3/c1-26-14-20(17-8-4-5-11-21(17)26)23-18-9-2-3-10-19(18)24(29)27(23)15-22(28)25-13-16-7-6-12-30-16/h2-12,14,23H,13,15H2,1H3,(H,25,28)/t23-/m0/s1

InChI Key

XTAGEHYDGAECFO-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD08674279

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

399.45

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.661

Distribution Coefficient, logD

3.661

Water Solubility, LogSw

-3.79

Polar Surface Area

50.797

Acid Dissociation Constant (pKa)

13.09

Base Dissociation Constant (pKb)

-1.33

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

16.70

F019-6063 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with F019-6063 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F019-6063?
Check Price and Availability of F019-6063, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F019-6063 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F019-6063
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F019-6063
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F019-6063 available by request